Association Between Dietary Anthocyanidin Intake and Thyroid Autoimmunity: A Cross‐Sectional Study From NHANES (2007–2010) Authors: Mingkuan Chen, Yirong Yuan, Yuan Zhao, Siyu Wu, Haitao Yang, Dun Xiong, Shaocai Xia Published: 2026 ABSTRACT ABSTRACTBackgroundDespite extensive documentation of the immunomodulatory effects of anthocyanidins, population‐based epidemiological studies have yet to elucidate their association with thyroid autoimmunity (TAI).MethodsUsing flavonoid intake data from the Flavonoid and Anthocyanidin Database (FNDDS) and 2007–2010 National Health and Nutrition Examination Survey (NHANES) datasets (n = 5,487), we constructed multivariable logistic regression and restricted cubic spline models to examine the dose–response relationship between the log10‐transformed anthocyanidin intake values (LgAAs) and TAI incidence, adjusting for demographic, anthropometric, and metabolic covariates.ResultsThe intake of anthocyanidins by TAI patients was significantly greater than that by controls [median (IQR): 2.20(0.00, 14.92) vs. 0.98 (0.00, 7.18) mg/d, p < 0.001]. Each unit increase in LgAA corresponded to a 16% increase in the risk of TAI (adjusted OR 1.16, 95% CI 1.04–1.29; p = 0.0088). Compared with the lowest quartile, the highest LgAA quartile was associated with a 47% increase in the incidence of TAI (OR 1.47, 95% CI 1.12–1.93; p = 0.0055; P trend = 0.014), with consistent associations across subgroups (P interaction = 0.528). Restricted cubic spline analysis confirmed a linear dose–response relationship (P nonlinearity = 0.217).ConclusionThis cross‐sectional study identified an association between dietary anthocyanidin intake and TAI. Future prospective cohort studies and randomized trials are warranted to validate our observations and elucidate underlying mechanisms. Introduction Autoimmune thyroid diseases represent one of the most prevalent organ‐specific autoimmune disorders. Circulating autoantibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) constitute the serological signature of thyroid autoimmunity (TAI) [1, 2]. TAI is the most frequent cause of thyroid dysfunction presenting as overt or subclinical hypothyroidism [3]. The last few decades have witnessed a steady surge in the epidemiology of (TAI), characterized predominantly by an increasing incidence of Hashimoto's thyroiditis (HT) [4, 5]. The incidence of HT is approximately four times greater in females than in males. According to statistics, the prevalence of HT in China is approximately 14.19% [6]. The clinical manifestations of Hashimoto's disease include a range of symptoms, such as mood swings, chronic fatigue, stress, and cardiovascular or gastrointestinal complications, and serum TPO‐Ab and TG‐Ab levels are positively correlated with the severity of the aforementioned symptoms [7, 8, 9]. Furthermore, increasing evidence has suggested a possible association between HT and thyroid cancer [10, 11, 12, 13]. Given the absence of targeted interventions to halt autoimmune‐mediated thyroid destruction, levothyroxine replacement therapy remains the cornerstone of management for TAI patients who progress to hypothyroidism [14]. Although the precise pathogenesis of TAI is remains incompletely understood, it is widely recognized to be driven by a complex interplay of genetic, epigenetic, and environmental factors [15, 16, 17, 18]. Dietary habits are significant contributing factors to the pathogenesis and progression of TAI. Previous epidemiological studies have identified a significant positive association between dietary fat intake and the risk of TAI [19]. Dietary modifications can serve as adjunctive therapeutic strategies to manage HT by influencing thyroid function and inflammatory status [8]. Many nutrients or dietary supplements with anti‐inflammatory properties, such as magnesium, zinc, selenium, vitamin D, antioxidants, monounsaturated and polyunsaturated fatty acids, and phytochemicals, are crucial for reducing thyroid inflammation [20, 21, 22]. Moreover, these dietary supplements may have a positive effect on symptoms of hypothyroidism, thereby improving patients' quality of life [20]. Accumulating evidence indicates that adherence to a predominantly plant‐based Mediterranean diet exerts a protective effect against TAI [23]. Flavonoids can be classified into several subcategories, including flavanones, flavones, flavanols, anthocyanidins, and flavonols, on the basis of the components they contain and are widely present in plant foods [24]. The most discussed aspect of flavonoids in human health is their diverse and extensive immunomodulatory effects [25, 26]. Among adults in the US, tea, wine, beer, citrus fruits, and apples constitute the primary sources of flavonoid intake [27]. Anthocyanidins are widely found in fruits and vegetables. The six anthocyanidins that have most commonly been detected in foods are delphinidin, cyanidin, pelargonidin, malvidin, petunidin, and peonidin [28, 29]. The antimicrobial, antioxidant, anti‐inflammatory, and antimutagenic properties of anthocyanidins contribute to the prevention and treatment of numerous chronic diseases, including metabolic disorders, cancer, and cardiovascular diseases [30, 31]. The two crucial pathophysiological factors underlying TAI are inflammation and oxidative stress. Nevertheless, the relationship between anthocyanidins and TAI has yet to be documented in the scientific literature. Accordingly, the objective of this study was to assess the impact of dietary anthocyanidins on TAI. Materials and Methods Study Population The NHANES database represents a comprehensive cross‐sectional study conducted by the National Center for Health Statistics (NCHS) with the objective of assessing the nutritional and health status of children and adults in the United States. The NHANES database comprises a range of data, including demographic information, questionnaire data, examination data, laboratory data, and limited access data. All the data collected were approved by the Ethics Review Board of the NCHS (https://www.cdc.gov/nchs/nhanes/). The data analyzed in this study were obtained from the NHANES and FNDDS for two survey cycles, which included 5,487 participants from 2007 to 2010. Demographic data, chronic disease information, laboratory data, and dietary information were collected. Participants whose complete dietary information about flavonoids was unavailable or whose thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) measurement data were missing were excluded. Figure 1 shows an overview of the screening procedure. Flow chart of participant selection. Measurement of Serum Thyroid Antibody Levels Blood samples obtained from the participants were collected, processed, stored, and shipped to the University of Washington in Seattle. A sequential two‐step immune enzymatic sandwich assay was conducted to measure TPOAb and TgAb levels. Details regarding the collection and processing of the samples are outlined in the NHANES LPM (Laboratory/Medical Technologists Procedures Manual). As an outcome variable in this study, we applied values of TgAb > 115.0 (IU/mL) or TPOAb > 9.0 (IU/mL) for TAI diagnosis [4]. Measurement of Dietary Anthocyanidin Intake This study focused on evaluating the intake of flavonoids from foods and beverages. Food types were refined using versions appropriate for different survey cycles according to the FNDDS, with version 4.1 used from 2007 to 2008 and version 5.0 used from 2009 to 2010. Flavonoid intake was quantified by combining the flavonoid content of various foods with the Food Frequency Questionnaire (FFQ), and the intake of medications or flavonoid supplements was not considered in this study. The 24‐h dietary recall method was used to collect dietary data on two separate occasions, which were collected by trained nutritionists. The first interview took place at the mobile screening center, while the second interview was conducted by telephone 3 to 10 days later. The mean intake from both sets of data was used as the final intake value in this study. Attribution analysis based on the FNDDS indicated that anthocyanidin intake was predominantly derived from a narrow range of foods, specifically berries, red grapes, and red wine. The value of anthocyanidin intake was presented as medians with interquartile ranges (IQR). Percentiles (P5, P25, P75, and P95) were calculated to fully characterize the intake distribution. Detailed information regarding the calculation of dietary flavonoid intake is available at https://www.ars.usda.gov/northeast-area/beltsville-md-bhnrc/beltsville-human-nutrition-research-center/food-surveys-research-group/docs/fndds/ [32]. Detailed nutritional information for all foods and beverages in FNDDS, and values for each flavonoid subclass are provided in Supportin Material. Covariates NHANES collected demographic and lifestyle information from participants via a standardized questionnaire. In our study, demographic and lifestyle information, including age, sex, race, education level, marital status, body mass index (BMI), alcohol use status, and smoking status, was collected. Race was divided into four categories: white, black, Mexican, and others. Education was divided into the following five categories: less than 9th grade, 9–11th grade, high school, some college, and college graduate or above. Marital status was classified as one of the following five categories: married, widowed, separated, living with a partner, and never married. Smoking status was categorized as follows: never (participants who had smoked fewer than 100 cigarettes in their lifetime), former (participants who had smoked more than 100 cigarettes in their lifetime but were not current smokers), and current (participants who had smoked more than 100 cigarettes in their lifetime and were current smokers). Alcohol use status was classified as never, former, mild, moderate, or heavy. Body mass index (BMI; kg/m2) was divided into the following categories: underweight (BMI < 18.5), normal (18.5 ≤ BMI < 24), overweight (24 ≤ BMI < 30), and obese (BMI ≥ 30). Moreover, chronic diseases, such as hypertension, hyperglycemia, hyperlipidemia, and cardiovascular disease (CVD), were also defined. The NHANES provides information on specific techniques and the determination of the quality of the data for relevant covariate control methods. Statistical Analyses Appropriate sample weights provided on the official NHANES website were employed to ensure that the samples were representative of the overall population. Since the flavonoid intake data exhibited non‐normal distributions, they are presented as median (IQR). Comparisons between the TAI group and the control group for continuous variables were performed using the weighted Wilcoxon rank‐sum test (Mann–Whitney U test). Categorical variables are expressed as weighted percentages (95% CIs) and were compared between groups using the weighted Pearson Chi‐square test. Given the right‐skewed distribution with a long right tail (1.95% of participants had intakes > 100 mg/d), the anthocyanidins intake data were natural log‐transformed (LgAAs) prior to parametric analyses. The LgAAs were divided into quartiles: Q1 (< 0.0065), Q2 (0.0065 to 0.5340), Q3 (0.5340 to 1.1232), and Q4 (1.1232 to 2.7355). A multivariate logistic regression analysis model was constructed to evaluate the adjusted odds ratios (ORs) and 95% CIs between the LgAA and diagnosis of TAI. Three models were subsequently constructed for analysis. The first model (Model 1) is the raw model, which did not adjust for any covariates. The second model (Model 2) was adjusted for age, sex, ethnicity, marital status, and education. Model 3 was adjusted for all the covariates. Furthermore, subgroup analyses were conducted on variables such as age, sex, race, education, marital status, smoking status, alcohol use, hyperglycemia, hypertension, hyperlipidemia, BMI, and CVD to assess the impact of heterogeneity. The potential linear relationship between LgAA and TAI was evaluated through the application of smooth curve fitting and generalized additive models. Statistical significance was set a priori at α = 0.05, and all tests were two‐sided unless otherwise specified. R software (version 4.3.2; http://www.r-project.org), RStudio software, the “nhanesR” package, and Empower® software (http://www.empowerstats.com; X&Y Solutions, Inc., Boston, MA, USA) were used for data extraction and statistical analyses. In the present study, WTDR2D was employed for all the data weights. Results Baseline Clinical Characteristics of the Study Participants A total of 5,487 participants were included in the study, of whom 662 were diagnosed with TAI, representing 12.06% of the total population. The mean age of all participants was 51.14 years, with 50.57% identified as female. As shown in Supporting 2.3, the anthocyanidins intake exhibited a right‐skewed distribution (Skewness = 6.39; Kurtosis = 60.09). The median intake was 1.03 mg/d, with the 25th and 75th percentiles being 0 and 6.84 mg/d, respectively. Of note, the arithmetic mean (10.85 mg/d) was markedly inflated by extreme high values (maximum: 536.5 mg/d) and does not represent the central tendency of the general population. Further inspection revealed that 25% of participants reported zero intake, whereas 107 individuals (1.95%) had intakes exceeding 100 mg/d, indicating a distinct subpopulation with high consumption. This distribution pattern aligns with the highly specific food sources of anthocyanidins in natural diets. Table 1 summarizes the demographic and baseline clinical characteristics of those enrolled. We compared dietary flavonoid intake between the non‐TAI and TAI groups. The dietary intake of anthocyanidins was greater in patients with TAI than in those without TAI 2.20(0.00,14.92) versus 0.98(0.00, 7.18), p < 0.001]. Individuals in the TAI group were more likely to be older, female, non‐Hispanic white, and married than those in the non‐TAI group were. Additionally, smoking and alcohol consumption status seemed to influence the occurrence of TAI, and participants with hyperglycemia and hyperlipidemia were more likely to be diagnosed with TAI. However, there was no significant difference in BMI, CVD, hypertension, or education between the two groups. Additional details are presented in Table 1. Table 1Characteristics of the participants (N = 5487).Characteristicnon‐TAITAI p valueIsoflavones (mg, M (IQR))0.00 (0.00, 0.04)0.00 (0.00, 0.04)0.650Anthocyanidins (mg, M (IQR))0.98 (0.00, 7.18)2.20 (0.00, 14.92) < 0.001 Flavan_3_ols (mg, M (IQR))11.94 (2.40, 117.36)16.55 (3.98, 180.11) 0.010 Flavanones (mg, M (IQR))0.28 (0.00, 6.09)0.46 (0.00, 15.06)0.060Flavones (mg, M (IQR))0.43 (0.11,1.07)0.54 (0.14, 1.16) 0.020 Flavonols (mg, M (IQR))12.20 (5.40, 23.66)12.66 (6.86, 24.10)0.120Total flavonoids (mg, M (IQR))67.95 (25.52, 275.43)82.41 (30.34, 322.33) 0.050 Age (years, mean (95% CI)) 47.18 (46.27, 48.10)52.38 (51.07, 53.69) < 0.001 Gender (percentage (95% CI) < 0.001 Female49.02 (47.71, 50.33)69.25 (64.32, 73.77)Male50.98 (49.67, 52.29)30.75 (26.23, 35.68) Race (percentage (95% CI)) < 0.001 White71.40 (65.62, 76.56)80.26 (74.86, 84.73)Mexican7.84 (5.89, 10.37)7.16 (5.13, 9.90)Black10.76 (8.16, 14.07)5.03 (3.27, 7.67)Other9.99 (7.80, 12.72)7.55 (5.14, 10.96) Marital status (percentage (95% CI)) < 0.001 Married57.69 (54.11, 61.20)62.77 (56.14, 68.95)Widowed5.48 (4.82, 6.22)11.40 (8.73, 14.75)Separated2.50 (1.99, 3.14)1.72 (0.99, 2.97)Living with partner7.47 (6.32, 8.80)5.15 (3.16, 8.29)Never married16.64 (14.09, 19.55)10.66 (7.31, 15.29)Divorced10.22 (9.06, 11.52)8.30 (6.02, 11.35) Education (percentage (95% CI)) 0.105Less than 9th grade6.13 (4.93, 7.60)4.72 (3.65, 6.09)9–11th grade13.07 (11.33, 15.04)10.28 (7.40, 14.11)High school25.00 (22.47, 27.71)24.31 (20.43, 28.66)Some college29.38 (27.64, 31.19)31.24 (27.14, 35.66)College graduate or above26.42 (22.86, 30.31)29.44 (24.33, 35.13) Hypertension (percentage (95% CI)) 0.746No63.14 (60.84, 65.39)62.41 (57.80, 66.80)Yes36.86 (34.61, 39.16)37.59 (33.20, 42.20) Hyperglycemia (percentage (95% CI)) 0.024 No77.37 (75.42, 79.21)72.14 (67.74, 76.16)DM13.55 (12.17, 15.07)14.99 (11.42, 19.43)IFG4.50 (3.91, 5.17)5.29 (3.51, 7.91)IGT4.58 (3.81, 5.49)7.57 (5.04, 11.22) Hyperlipidemia (percentage (95% CI)) 0.0022 No26.00 (24.08, 28.02)19.22 (16.11, 22.76)Yes74.00 (71.98, 75.92)80.78 (77.24, 83.89) CVD (percentage (95% CI)) 0.956No91.09 (89.81, 92.22)91.01 (87.18, 93.78)Yes8.91 (7.78, 10.19)8.99 (6.22, 12.82) Smoking status (percentage (95% CI)) < 0.001 Never52.34 (49.26, 55.39)59.77 (54.85, 64.50)Former26.01 (24.47, 27.62)26.10 (21.60, 31.16)Now21.65 (19.50, 23.96)14.14 (11.15, 17.76) Alcohol use (percentage (95% CI)) 0.0176 Never11.06 (9.76, 12.52)12.51 (9.20, 16.79)Former17.40 (14.85, 20.30)16.36 (13.66, 19.49)Mild33.79 (31.05, 36.64)39.23 (32.29, 46.63)Moderate16.45 (14.65, 18.42)18.08 (13.94, 23.10)Heavy21.30 (19.76, 22.93)13.82 (9.43, 19.80) BMI (percentage (95% CI)) 0.189Underweight1.25 (0.87, 1.80)2.13 (1.00, 4.48)Normal22.21 (20.54, 23.98)21.92 (18.23, 26.11)Overweight41.39 (39.86, 42.93)45.00 (39.43, 50.70)Obese35.15 (33.29, 37.06)30.95 (26.64, 35.62) Note: Bold values indicate statistically significant values (p < 0.05).Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; IFG, impaired fasting glycemia; IGT, impaired glucose tolerance; M(IQR), medians (interquartile ranges); TAI, thyroid autoimmunity; 95% CI, 95% confidence interval.John Wiley & Sons, Ltd. Characteristics of the participants (N = 5487). Note: Bold values indicate statistically significant values (p < 0.05). Abbreviations: BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; IFG, impaired fasting glycemia; IGT, impaired glucose tolerance; M(IQR), medians (interquartile ranges); TAI, thyroid autoimmunity; 95% CI, 95% confidence interval. Association Between Dietary Anthocyanidin Intake and TAI To investigate the association between the LgAA and TAI, a multivariate logistic regression model was constructed (Table 2). A unit increase in LgAA was associated with a 28% increased risk of TAI in Model 1 (without variable adjustment) (OR 1.28; 95% CI 1.16, 1.43; p < 0.001). A unit increase in LgAA was associated with a 17% increased risk of TAI in Model 2 (OR 1.17; 95% CI 1.05, 1.34; p = 0.0034). In Model 3 (adjusted for all covariates), a per‐unit increase in LgAA was associated with a 16% increased risk of TAI (OR 1.16; 95% CI 1.04, 1.29; p = 0.0088). Additionally, we transformed the LgAA into a categorical variable (Q1–4), and both the unadjusted and adjusted models showed significant p values for trends. Compared with the Q1 group, the highest dietary intake of anthocyanidins (Q4 group) was independently associated with a greater incidence of TAI after adjustment for all potential confounding variables (OR 1.47; 95% CI 1.12, 1.93, p = 0.0055). These findings suggest that increased consumption of anthocyanidins is linked to an increased likelihood of developing TAI. Table 2Association between LgAA and TAI according to different models.VariableModel 1 (OR (95% CI) p value)Model 2 (OR (95% CI) p value)Model 3 (OR (95% CI) p value)LgAAs1.28 (1.16, 1.43) < 0.00011.17 (1.05, 1.31) 0.00341.16 (1.04, 1.29) 0.0088LgAAs (quartile)Q1Ref.Ref.Ref.Q21.45 (1.11, 1.89) 0.00701.39 (1.06, 1.83) 0.01771.37 (1.04, 1.80) 0.025Q31.42 (1.09, 1.86) 0.01051.24 (0.95, 1.64) 0.11961.22 (0.92, 1.61) 0.164Q41.85 (1.43, 2.39) < 0.00011.52 (1.17, 1.99) 0.00211.47 (1.12, 1.93) 0.0055 P for trend1.20 (1.10, 1.30) < 0.00011.12 (1.03, 1.21) 0.00881.10 (1.02, 1.20) 0.021 Note: Model 1: Raw model without covariate adjustments. Model 2: Adjusted for age, sex, ethnicity, marital status, and education. Model 3: Adjustments in Model 2 plus adjustments for smoking status, alcohol use status, BMI, hypertension, hyperlipidemia, and CVD. OR, odds ratio; 95% CI, 95% confidence interval.Abbreviations: LgAAs, log10‐transformed anthocyanidin intake value; TAI, thyroid autoimmunity.John Wiley & Sons, Ltd. Association between LgAA and TAI according to different models. Note: Model 1: Raw model without covariate adjustments. Model 2: Adjusted for age, sex, ethnicity, marital status, and education. Model 3: Adjustments in Model 2 plus adjustments for smoking status, alcohol use status, BMI, hypertension, hyperlipidemia, and CVD. OR, odds ratio; 95% CI, 95% confidence interval. Abbreviations: LgAAs, log10‐transformed anthocyanidin intake value; TAI, thyroid autoimmunity. The Relationship Between Dietary Anthocyanidin Intake and the Risk of TAI Is Linear After adjusting for all potential confounding variables, smooth curves were constructed to determine the potential relationship between dietary anthocyanidin intake (LgAA) and the risk of TAI (Figure 2). The findings indicated that there was a significant positive linear correlation between anthocyanidin intake and the risk of TAI. Correlation between LgAA and TAI. A linear correlation between LgAA and TAI was detected using a generalized additive model (GAM). The solid red line represents the smooth curve fit between variables. The blue bands represent the 95% confidence interval from the fitted curve. All variables were adjusted for (age, sex, ethnicity, marital status, education, smoking status, alcohol use status, BMI, hypertension, hyperlipidemia, and CVD). Stratified Analysis Further investigation of the associations between dietary anthocyanidin intake and TAI in different populations was conducted through stratified analysis. The results demonstrated that the association between dietary anthocyanidin intake and TAI remained stable and was not significantly affected by other covariates (Figure 3). Stratified associations between dietary anthocyanidin intake and TAI. Age, sex, ethnicity, marital status, education, smoking status, alcohol use status, BMI, hypertension, hyperlipidemia, and CVD were adjusted for. Abbreviations: TAI, Thyroid autoimmunity; DM, diabetes mellitus; IFG, impaired fasting glycemia; IGT, impaired glucose tolerance; CVD, cardiovascular disease; BMI, body mass index; 95% CI, 95% confidence interval. Discussion The global incidence of autoimmune thyroid diseases has risen markedly in recent decades, a trend largely attributable to environmental exposures linked to contemporary lifestyle transitions. Dietary patterns that prioritize plant‐derived proteins and lipids over animal‐based sources represent a viable lifestyle intervention for mitigating the risk of TAI [23]. Flavonoids are widely present in fruits and vegetables; have a variety of pharmacological effects, such as anticancer, antioxidant, and anti‐inflammatory effects; and reduce vascular fragility [25]. A systematic review elucidated the protective role of flavonoids against diverse autoimmune diseases, including type 1 diabetes mellitus (T1DM), multiple sclerosis (MS), psoriasis, inflammatory bowel disease (IBD), and systemic lupus erythematosus (SLE) [33]. Anthocyanidins are important members of the flavonoid family, and our study revealed a significant difference in dietary anthocyanidin intake between TAI and non‐TAI participants. In this study, a cross‐sectional analysis was conducted on a large, representative U.S. population to investigate the relationship between dietary anthocyanidin intake and TAI. To the best of our knowledge, our study is the first to analyze the association between dietary anthocyanidin intake and TAI. In our study, compared with those in the non‐TAI group, individuals in the TAI group were more likely to be older, female, non‐Hispanic white, and married. The prevalence of TAI was greater in females than in males, which is consistent with the findings of most previous studies [34, 35]. Moreover, our study revealed that compared with males, females consumed more anthocyanidins in each quartile (Q1–Q4) of anthocyanidin intake. Interestingly, dietary anthocyanidin intake was positively associated with TAI in the 2007–2010 NHANES datasets. The results of the analysis revealed a linear correlation between dietary anthocyanidin intake and the risk of TAI. This was demonstrated by weighted multivariate logistic regression models, which were fully covariate adjusted and contained sociodemographic, laboratory, questionnaire, dietary and comorbidity data. After categorizing dietary anthocyanidin intake, we observed a 47% increase in the prevalence of TAI among the participants in the highest dietary anthocyanidin intake quartile (Q4). These results suggest that anthocyanidin intake may serve as a reliable predictor of TAI in adults in the US. Studies on the relationship between anthocyanidins and human health have focused mainly on their antioxidant, anti‐inflammatory, cardioprotective, and immunomodulatory effects [31, 36, 37]. It can be reasonably inferred that there may be a direct or indirect association between dietary anthocyanidin intake and TAI. However, no prior investigations have been conducted to elucidate this potential relationship. TAI is the result of a complex interplay between genetic predispositions, environmental risk factors and epigenetic influences. In addition, increases in intestinal permeability and the abundance of metabolites produced by the intestinal flora may affect systemic immune status, suggesting that the gut–thyroid axis may play an important role in the pathogenesis of TAI [38, 39, 40]. Evidence suggests that conditions such as intestinal bacterial overgrowth, dysbiosis and increased intestinal permeability may contribute to the development of TAI, such as Yersinia pestis or Helicobacter pylori infection in the small intestine [41]. Significant differences in dietary habits and gut microbial alterations were observed in hashimoto's thyroiditis patients; patients with hashimoto's thyroiditis consumed more vegetables, proteins, and saturated fats daily than the control patients did [42]. Notably, dietary fat is associated with a reduction in microbiota diversity and abundance, which in turn increases gut permeability and low‐grade systemic inflammation [43]. In patients with TAI, the increase in intestinal permeability facilitates the migration of toxins, bacterial metabolites, and antigens from the gut into the bloodstream [44, 45]. Therefore, does increased anthocyanidin intake in the general population result in an elevated risk of TAI through the above mechanisms? Further investigations are warranted to substantiate this hypothesis. In addition, anthocyanins have been shown to increase antioxidant enzyme activities and modify the composition and diversity of the gut microbiome in oxidatively damaged mice [46]. The consumption of anthocyanidins may confer health benefits by influencing cellular antioxidant status and inflammation. This may result in an inverse relationship between fruit and vegetable intake and the incidence of chronic disease. Notably, phytoestrogen (PET) has been shown to reduce the levels of TPOAb, TgAb, and inflammatory markers such as CD4, IFN‐γ, and IL‐17, thereby alleviating thyroid dysfunction. The specific mechanism of PET in HT mice may involve the inhibition of apoptosis, oxidative stress, and Th1/Th17 differentiation by regulating the NOX4/PKM2 axis [47]. Nevertheless, our findings indicate a positive correlation between anthocyanin intake and the likelihood of developing TAI. This finding warrant further prospective studies to validate this association and elucidate its underlying mechanisms. When interpreting the substantial interindividual variability in anthocyanin intake observed in this study, the potential modifying effect of food processing on actual exposure must be considered. Firstly, the inherent chemical lability of anthocyanins renders them highly susceptible to degradation; conventional culinary practices—such as baking and boiling—can deplete native compounds in the food matrix by over 50%. However, the FNDDS and the dietary recall methodology employed herein capture only static nutrient values of raw ingredients or finished products, lacking individual‐level correction factors for cooking losses. This limitation likely contributes to the artificial inflation of ‘zero’ and ‘low’ intake values. Secondly, and more critically, the notoriously low oral bioavailability of anthocyanins (< 1%) results in negligible circulating concentrations of intact parent compounds [48]. Current consensus posits that the primary health benefits of anthocyanins are mediated by phenolic acid metabolites generated via colonic microbial biotransformation [49]. Consequently, specific processing techniques—notably fermentation or mild homogenization—that facilitate the hydrolysis of polymeric anthocyanins may paradoxically reduce colonic transit lag time and enhance the cumulative yield of bioactive metabolites. Given the cross‐sectional design of this study, which lacked granular data on cooking habits (e.g., water pH, heating duration) and individual gut microbiota profiles, our reported ‘intake’ represents a conservative and crude proxy for actual anthocyanin exposure. Future investigations should incorporate food processing correction models utilizing retention factors to refine dose estimates, thereby mitigating the risk of misclassifying the true health associations of these compounds. It should be noted, however, that the study is not without limitations. First, as a cross‐sectional study, determining the causal relationship between dietary anthocyanidin intake and TAI was not possible, and we cannot rule out the possibility of reverse causality, meaning that individuals known to have thyroid disease may have already altered their dietary habits. Second, anthocyanidin intake likely reflects broader dietary patterns rather than acting as an independent exposure. Despite multivariable adjustment, the inherent collinearity among these diet‐ and lifestyle‐related variables precludes definitive isolation of an independent effect; thus, the observed association cannot be conclusively attributed to anthocyanidin intake per se and should be interpreted within the context of overall dietary habits. Future studies employing advanced dietary pattern analyses or intervention designs are needed to disentangle these effects. Third, the use of a 24‐h dietary recall interview for dietary assessment may result in errors when estimating actual intake, and this method may not accurately reflect long‐term dietary habits and is susceptible to seasonal variations and recall bias. Notably, the 107 participants with extremely high anthocyanidin intakes identified in this study likely reflect specific dietary habits, such as a heavy reliance on particular berry staples, which deviate from typical consumption patterns. Caution is therefore warranted when extrapolating these findings to the general population. We also acknowledge the outcome misclassification may have occurred despite standardized protocols. Furthermore, objective metrics for the quantification of anthocyanidin intake are lacking. Finally, other residual confounders, such as physical activity, other dietary components, food processing, dietary supplements, and medications, were not considered, which may affect the accuracy of the association between anthocyanin intake and TAI. Multiple comparisons were not strictly corrected in the statistical analysis, increasing the likelihood of chance findings. In conclusion, while this study identifies a significant association between dietary anthocyanidin intake and HT prevalence, the cross‐sectional design precludes causal inference. The observed relationship may be attributable to reverse causation, residual confounding, or broader dietary patterns rather than a direct effect of anthocyanidins. These findings should be considered hypothesis‐generating rather than evidence of causation, underscoring the need for prospective cohort studies and randomized controlled trials to elucidate the temporal relationship and potential mechanisms involved. Conclusions In summary, our findings provide the first evidence of an association between dietary anthocyanidin intake and thyroid autoimmunity (TAI). These results warrant further prospective studies to confirm this relationship and explore its potential implications. Author Contributions Mingkuan Chen: writing – original draft, software, methodology, project administration, validation, visualization. Yirong Yuan: writing – original draft, software, visualization. Yuan Zhao: methodology, writing – review and editing. Siyu Wu: validation. Haitao Yang: investigation. Dun Xiong: conceptualization, project administration. Shaocai Xia: conceptualization, methodology, project administration, writing – review and editing. Ethics Statement This work was conducted in accordance with the guidelines laid out in the Declaration of Helsinki, and all procedures involving research study participants were approved by the institutional review board of the National Center for Health Statistics (NCHS). All the participants provided written informed consent. Further details on NHANES ethics approval are available on the CDC' official website: https://www.cdc.gov/nchs/nhanes/about/erb.html?CDC_AAref_Val=https://www.cdc.gov/nchs/nhanes/irba98.htm. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement Shaocai Xia affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained. Supporting information Supporting File 1 Supporting File 2